Ruikang Pharmaceutical (002589.SZ) released its report for the first quarter of 2024, achieving 20 operating income during the reporting period...
According to the Zhitong Finance App, Ruikang Pharmaceutical (002589.SZ) released its report for the first quarter of 2024. During the reporting period, it achieved revenue of 2,019 billion yuan, a year-on-year decrease of 2.62%. Net profit attributable to shareholders of listed companies was 15.169 million yuan, a year-on-year decrease of 28.31%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was $18.1622 million.